CARL ZEISS MEDITEC ADR 1 Cash Flow Reinvestment Rate
CARL ZEISS MEDITEC ADR 1 cash flow reinvestment rate. CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €16.70 Million. See financial agility of CARL ZEISS MEDITEC ADR 1 to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CARL ZEISS MEDITEC ADR 1 (2022–2025)
Cash flow reinvestment rate of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. Historical reinvestment intensity for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Explore AFXA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
CARL ZEISS MEDITEC ADR 1 Cash Flow Reinvestment Rate by Year (2022–2025)
CARL ZEISS MEDITEC ADR 1 cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for CARL ZEISS MEDITEC ADR 1. For the full cash flow conversion analysis, see AFXA cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | €102.25 Million | €209.86 Million | €76.59 Million | ▼ -86.6% |
| 2024 | 3.63x | €898.32 Million | €247.32 Million | €152.20 Million | ▲ +617.2% |
| 2023 | 0.51x | €127.05 Million | €250.86 Million | €113.86 Million | ▼ -27.9% |
| 2022 | 0.70x | €132.13 Million | €188.20 Million | €81.97 Million | — |